Cargando…
MicroRNA‐338‐5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id‐1
5‐Fluorouracil (5‐FU) is a chemotherapeutic agent commonly used to treat esophageal squamous cell carcinoma (ESCC), but acquisition of chemoresistance frequently occurs and the underlying mechanisms are not fully understood. We found that microRNA (miR)‐338‐5p was underexpressed in ESCC cells with a...
Autores principales: | Han, Liang, Cui, Di, Li, Bin, Xu, Wen Wen, Lam, Alfred King Y., Chan, Kin Tak, Zhu, Yun, Lee, Nikki P.Y., Law, Simon Y.K., Guan, Xin Yuan, Qin, Yan Ru, Chan, Kwok Wah, Ma, Stephanie, Tsao, Sai Wah, Cheung, Annie L.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890449/ https://www.ncbi.nlm.nih.gov/pubmed/31646712 http://dx.doi.org/10.1111/cas.14220 |
Ejemplares similares
-
Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
por: Xu, Wen Wen, et al.
Publicado: (2014) -
Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer
por: Zhu, Yun, et al.
Publicado: (2021) -
Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression
por: Xu, Wen Wen, et al.
Publicado: (2017) -
Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance
por: Li, Bin, et al.
Publicado: (2019) -
Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
por: Li, Bin, et al.
Publicado: (2014)